切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 129 -133. doi: 10.3877/cma.j.issn.1674-3903.2023.03.001

器官捐献

器官捐献者转介时的临床特征分析
刘剑戎, 范明明, 郭煜()   
  1. 510630 广州,中山大学附属第三医院外科重症监护室
    510080 广州,广东药科大学附属第一医院输血科
  • 收稿日期:2022-10-14 出版日期:2023-06-25
  • 通信作者: 郭煜

Analysis of clinical characteristics of organ donors at referral

Jianrong Liu, Mingming Fan, Yu Guo()   

  1. Department of Surgical Intensive Care Unit, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    Department of Blood Transfusion, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China
  • Received:2022-10-14 Published:2023-06-25
  • Corresponding author: Yu Guo
引用本文:

刘剑戎, 范明明, 郭煜. 器官捐献者转介时的临床特征分析[J]. 中华移植杂志(电子版), 2023, 17(03): 129-133.

Jianrong Liu, Mingming Fan, Yu Guo. Analysis of clinical characteristics of organ donors at referral[J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(03): 129-133.

目的

分析器官捐献者转介时的临床特征变化,为器官捐献者临床管理策略的优化提供依据。

方法

回顾性分析2016至2019年中山大学附属第三医院器官获取组织完成的218例器官捐献者临床资料。比较不同年份器官捐献者转介时留置静脉管路情况、病原体携带情况,以及血红蛋白、血白蛋白和血钠等内环境指标,采用血管活性药物评分(VIS)评估捐献者血管活性药物使用情况。比较转介时留置不同静脉管路的器官捐献者VIS。

结果

218例器官捐献者中,男性185例,女性33例,平均年龄(42±15)岁。2016至2019年分别完成35、48、50和85例公民逝世后器官捐献。不同年份器官捐献者性别、年龄和血型等构成差异均无统计学意义(P均>0.05)。218例器官捐献者转介时均留置静脉管路并不同程度地使用血管活性药物,留置上腔静脉导管、下腔静脉导管和外周静脉导管的捐献者分别为149、29和40例。2016至2019年上腔静脉导管使用率分别为48.6%、68.8%、58.0%和82.4%,VIS分别为(74±49)、(51±43)、(65±57)和(49±44)分,差异均有统计学意义(χ2/F=29.65、2.90,P均<0.05)。上腔静脉导管组VIS为(34±27)分,低于下腔静脉导管组和外周静脉导管组[(110±50)和(105±45)分],差异有统计学意义(P均<0.05)。器官捐献者转介时痰液标本病原体培养阳性率最高,不同年份差异有统计学意义(χ2=62.52,P<0.05)。器官捐献者转介时血红蛋白、血白蛋白和血钠均处于异常水平,不同年份差异均无统计学意义(P均>0.05)。

结论

器官捐献者转介前的临床管理仍需继续完善,除电解质紊乱、贫血和低蛋白血症外,静脉通道的选择和感染防控需得到更多关注。

Objective

To analyze the changes of clinical characteristics of organ donors at the time of referral, and to provide evidence for optimizing the clinical management strategies of organ donors.

Methods

The clinical data of 218 organ donors from the Third Affiliated Hospital of Sun Yat-sen University from 2016 to 2019 were analyzed retrospectively. Indwelling venous catheter, pathogen infection, and internal environment parameters such as hemoglobin, serum albumin and serum sodium were compared during organ donor referral in different years, and vasoactive drug use in donors was assessed using the vasoactive-inotropic score(VIS). Compared the VIS of organ donors with different intravenous catheter at the time of referral.

Results

Of the 218 organ donors, 185 were male and 33 were female, with an average age of (42±15) years. Thirty-five, 48, 50 and 85 cases of organ donation after citizen′s death were completed from 2016 to 2019, respectively. There were no significant differences in sex, age and blood group composition of organ donors in different years (P>0.05 for all). The use rates of superior vena cava catheters from 2016 to 2019 were 48.6%, 68.8%, 58.0% and 82.4%, respectively, and the difference was statistically significant (χ2=29.65, P<0.05). From 2016 to 2019, the VIS of organ donors at referral was (74±49), (51±43), (65±57) and (49±44) points, respectively, and the difference was statistically significant (F=2.90, P<0.05); among them, the VIS of the superior vena cava catheter group was (34±27) points, which was lower than that of the inferior vena cava catheter group and the peripheral vena cava catheter group [(110±50) and (105±45) points], and the difference was statistically significant (P<0.05 for all). The positive rate of pathogen culture in sputum samples was the highest, and the difference was statistically significant in different years (χ2=62.52, P<0.05). Hemoglobin, serum albumin and serum sodium were at abnormal levels during organ donor referral, and there were no significant differences in different years (P>0.05 for all).

Conclusions

The clinical management of organ donors before referral still needs to be improved. In addition to electrolyte imbalance, anemia and hypoproteinemia, the selection of venous access and infection prevention and control need to be paid more attention.

表1 中山大学附属第三医院2016至2019年公民逝世后器官捐献者人口统计学资料比较
图1 中山大学附属第三医院2016至2019年公民逝世后器官捐献者转介时留置静脉管路及血管活性药物评分注:a.静脉管路留置情况;b.血管活性药物评分
表2 中山大学附属第三医院2016至2019年公民逝世后器官捐献者转介时病原体携带及内环境情况
1
中国器官移植发展基金会. 中国器官移植发展报告(2021)[M]. 北京:人民卫生出版社,2022.
2
刘剑戎,熊天威,周密,等.供者管理模式对器官捐献结局的影响[J/CD]. 中华肝脏外科手术学电子杂志202110(6):589-593.
3
Sarıtaş A, Acar Çinleti B, Zincircioğlu Ç et al. Brain death in intensive care units: problems, differences in methods of diagnosis, and donor care[J]. Exp Clin Transplant, 2018.
4
甄志勇,郭丽娟,薛增珍,等. 重症颅脑损伤病人炎症反应与凝血机制特点分析[J]. 中西医结合心脑血管病杂志202018(18):3100-3104.
5
Frenette AJ, Charbonney E, D′Aragon F, et al. A Canadian survey of critical care physicians′ hemodynamic management of deceased organ donors[J] .Can J Anaesth, 2019, 66(10): 1162-1172.
6
McDonald MF, Barrett SC, Malik TH, et al. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes[J]. Transpl Int, 202134(10): 1971-1983.
7
Finger MA, Cipullo R, Rossi Neto JM, et al. Donor hypernatremia and smoking addiction contribute to primary graft failure in heart transplantation[J]. Clin Transplant, 201933(10): e13693.
8
Corbel A, Ladrière M, Le Berre N, et al. Microbiological epidemiology of preservation fluids in transplanted kidney: a nationwide retrospective observational study[J]. Clin Microbiol Infect, 202026(4): 475-484.
9
Chen Z, Su Y, Liu G, et al. Investigation of apnea testing during brain death determination in China[J] ASAIO J, 202167(11): 1211-1216.
10
王琳,吴楠. 重症患者休克时快速建立可靠静脉通道的对策及应用体会[J]. 世界最新医学信息文摘201717(11):173.
11
陶新曹,刘国梁,申艳玲,等. 重症患者静脉输液通路选择策略的调查研究[J]. 中国呼吸与危重监护杂志201615(1):57-59.
12
亚洲急危重症协会中国腹腔重症协作组. 重症患者中心静脉导管管理中国专家共识(2022版)[J]. 中华消化外科杂志202221(3):313-322.
13
孟学刚,地力木拉提,李江,等. 持续中心静脉压监测在神经重症患者中应用价值探讨[J]. 中国实用神经疾病杂志201821(2):143-146.
14
Hyun J, Kim AR, Lee SE, et al. Vasoactive-inotropic score as a determinant of timely initiation of venoarterial extracorporeal membrane oxygenation in patients with cardiogenic shock[J]. Circ J, 202286(4):687-694.
15
朱有华. DCD供者来源感染现状与防控策略[J/CD]. 实用器官移植电子杂志2018, 6(1):49-50.
16
中华医学会器官移植学分会. 器官移植供者来源性感染诊疗技术规范(2019版)[J]. 器官移植201910( 4):369-375.
17
张建蕊,孙丽莹,朱志军,等. 供者来源性感染对肝移植受者的影响[J/CD]. 实用器官移植电子杂志20186(1): 17-20.
18
Benamu E, Pereira MR, Taimur S, et al. Isolation of antibiotic-resistant gram-negative organisms from donor respiratory culture does not impact non-lung solid organ recipient management[J]. Clin Transplant, 201933(8):e13646.
19
中华医学会器官移植学分会,中国医师协会器官移植医师分会. 中国公民逝世后捐献供器官功能评估和维护专家共识( 2016版)[J/CD]. 中华移植杂志:电子版201610(4):145-153.
20
中华医学会器官移植学分会. 尸体器官捐献供体及器官评估和维护规范( 2019版)[J]. 器官移植2019, 10(3):47-56.
21
Raios C, Keating JL, Stitt N, et al. Challenges in providing imely physiotherapy and opportunities to influence outcomes for potential lung donors[J]. Prog Transplant, 2017, 27(2): 112-124.
22
姜涛,郭军,杨杨,等. 公民逝世后器官捐献成功与失败的因素分析[J]. 医学与哲学201940(8): 18-21.
23
王绅. 血钠及其波动在颅脑创伤中的意义[D]. 上海:上海交通大学,2020.
[1] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[2] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[3] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[4] 叶啟发, 兰佳男. 中国人体器官捐献与异种移植[J]. 中华移植杂志(电子版), 2023, 17(04): 221-226.
[5] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[6] 艾紫叶, 李玲, 何重香, 黄伟, 叶啟发. 猪器官异种移植研究进展[J]. 中华移植杂志(电子版), 2023, 17(03): 186-191.
[7] 杨锦然, 李新长, 何小平, 傅俊, 龙成美, 陈志铭. 不破坏膈肌式肝肾联合获取术总结分析[J]. 中华移植杂志(电子版), 2023, 17(03): 146-151.
[8] 国家传染病医学中心, 中华医学会器官移植学分会, 中国康复医学会器官移植康复专业委员会, 中国器官移植发展基金会器官移植受者健康管理专项基金. 实体器官移植受者新型冠状病毒感染诊疗专家共识(2023年版)[J]. 中华移植杂志(电子版), 2023, 17(02): 65-81.
[9] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 心肾联合移植三例[J]. 中华移植杂志(电子版), 2023, 17(02): 124-127.
[10] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 新型冠状病毒感染流行下我国器官捐献者筛选规则是否应时而变?[J]. 中华移植杂志(电子版), 2023, 17(02): 82-88.
[11] 中国器官移植发展基金会器官移植受者健康管理专家委员会. 器官移植受者新型冠状病毒感染防治策略与健康管理中国专家指导意见(第一版)[J]. 中华移植杂志(电子版), 2023, 17(01): 1-12.
[12] 罗静, 王霞, 高上兰, 张彬霞, 廖菲. 5A+5R式管理干预在慢性阻塞性肺疾病患者肺康复中的应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 429-431.
[13] 师佩, 邱璐, 魏东东, 金发光, 顾兴. 光动力治疗肺癌患者的临床管理及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 427-428.
[14] 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式肝移植血管分割与重建中国专家共识[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 167-172.
[15] 程庆砾. 新冠病毒感染与肾脏[J]. 中华肾病研究电子杂志, 2023, 12(04): 240-240.
阅读次数
全文


摘要